Two Sigma Investments’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.42M Buy
522,047
+51,521
+11% +$662K 0.01% 1653
2025
Q4
$4.87M Buy
470,526
+410,854
+689% +$3.71M 0.01% 1744
2025
Q3
$354K Buy
+59,672
New +$437K ﹤0.01% 3143
2025
Q2
Sell
-14,796
Closed -$112K 3217
2025
Q1
$112K Sell
14,796
-27,409
-65% -$263K ﹤0.01% 2953
2024
Q4
$514K Buy
42,205
+19,261
+84% +$277K ﹤0.01% 2529
2024
Q3
$384K Sell
22,944
-34,417
-60% -$610K ﹤0.01% 2574
2024
Q2
$1M Buy
+57,361
New +$1.22M ﹤0.01% 1985
2024
Q1
Sell
-50,342
Closed -$513K 3061
2023
Q4
$513K Buy
+50,342
New +$446K ﹤0.01% 2444
2022
Q4
Sell
-13,100
Closed -$168K 2825
2022
Q3
$168K Sell
13,100
-700
-5% -$9.43K ﹤0.01% 2145
2022
Q2
$177K Buy
13,800
+587
+4% +$6.66K ﹤0.01% 2185
2022
Q1
$138K Sell
13,213
-2,913
-18% -$39.4K ﹤0.01% 2393
2021
Q4
$249K Buy
+16,126
New +$322K ﹤0.01% 3773

Other funds holding CGEM